1. Home
  2. CYH vs MOBI Comparison

CYH vs MOBI Comparison

Compare CYH & MOBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Community Health Systems Inc.

CYH

Community Health Systems Inc.

SELL

Current Price

$2.02

Market Cap

411.7M

Sector

Health Care

ML Signal

SELL

Logo Mobia Medical Inc. Common Stock

MOBI

Mobia Medical Inc. Common Stock

SELL

Current Price

$12.57

Market Cap

383.0M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CYH
MOBI
Founded
1985
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Hospital/Nursing Management
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
411.7M
383.0M
IPO Year
2000
2026

Fundamental Metrics

Financial Performance
Metric
CYH
MOBI
Price
$2.02
$12.57
Analyst Decision
Hold
Strong Buy
Analyst Count
10
4
Target Price
$2.51
★ $18.00
AVG Volume (30 Days)
★ 2.2M
183.8K
Earning Date
10-28-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 196.67
N/A
EPS
★ N/A
N/A
Revenue
★ $12,485,000,000.00
N/A
Revenue This Year
N/A
$71.88
Revenue Next Year
N/A
$43.02
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.04
$8.03
52 Week High
$3.92
$15.19

Technical Indicators

Market Signals
Indicator
CYH
MOBI
Relative Strength Index (RSI) 33.59 58.90
Support Level $2.04 $10.55
Resistance Level $3.04 $13.85
Average True Range (ATR) 0.18 1.11
MACD -0.01 0.16
Stochastic Oscillator 3.06 64.75

Price Performance

Historical Comparison
CYH
MOBI

About CYH Community Health Systems Inc.

Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.

About MOBI Mobia Medical Inc. Common Stock

Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The company develops, markets and sells devices for the treatment of medical conditions. Its flagship device is the Vivistim Paired Vagus Nerve Stimulation system, which is used to support motor function rehabilitation in patients with chronic ischemic stroke. The company generates all of its revenue from the sale of the Vivistim System to customers, mainly primary and comprehensive stroke centers, in the United States.

Share on Social Networks: